US 12,258,333 B2
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
Elizabeth Mary Beck, Abingdon (GB); Steven John Durrant, Headington (GB); Sarah Skerratt, Cambridge (GB); Robert Pullin, Oxford (GB); Gorka Etxebarria Jardi, Badalona (ES); David Matthew Shaw, Oxford (GB); Nadia M. Ahmad, Hayes (GB); Christopher Wray, Berkshire (GB); Anisa Nizarali Virani, Thatcham (GB); Kiri North, Oxford (GB); James Dodd, Wallingford (GB); Michael Edward O'Donnell, Abingdon (GB); Bhairavi Galan, Abingdon (GB); Ronald Marcellus Knegtel, Abingdon (GB); Ewa Iwona Chudyk, Wantage (GB); Joanne Louise Pinder, Didcot (GB); Stephen Andrew Thomson, Durham, NC (US); Lidio Marx Carvalho Meireles, San Marcos, CA (US); Dean Stamos, Carlsbad, CA (US); Yvonne Schmidt, San Diego, CA (US); Joseph Pontillo, San Diego, CA (US); Sara S. Hadida Ruah, La Jolla, CA (US); Timothy Donald Neubert, San Diego, CA (US); Dennis James Hurley, San Marcos, CA (US); and Jinglan Zhou, San Diego, CA (US)
Assigned to VERTEX PHARMACEUTICALS INCORPORATED, Boston, MA (US)
Filed by VERTEX PHARMACEUTICALS INCORPORATED, Boston, MA (US)
Filed on Oct. 20, 2023, as Appl. No. 18/491,021.
Application 18/491,021 is a continuation of application No. 17/831,842, filed on Jun. 3, 2022, granted, now 11,827,627.
Claims priority of provisional application 63/196,946, filed on Jun. 4, 2021.
Prior Publication US 2024/0182455 A1, Jun. 6, 2024
Int. Cl. C07D 405/12 (2006.01)
CPC C07D 405/12 (2013.01) 22 Claims
 
1. A compound of formula (I-A-2):

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof, wherein:
Rd is (CH2)m(CHRe)n(CH2)pH;
m, n, and p are each independently 0 or 1;
Re is H, OH, halo, C1-C6 alkoxy, or C1-C6 haloalkoxy;
R4b1 and R4b2 are each independently H, C1-C6 alkyl, C3-C6 cycloalkyl, or C1-C6 haloalkyl;
R5b1 and R5b2 are each independently H, C1-C6 alkyl, C3-C6 cycloalkyl, or C1-C6 haloalkyl;
R2c is H, OH, halo, C1-C6 alkyl, C2-C6 alkenyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, or -L1-L2-(C3-C6 cycloalkyl), wherein said cycloalkyl is optionally substituted with 1-2 halo;
L1 is a bond or O;
L2 is a bond or C1-C6 alkylene;
R3c is H, halo, C1-C6 alkyl, or C1-C6 haloalkyl; or
R2c and R3c, together with the carbon atoms to which they are attached, form a ring of formula:

OG Complex Work Unit Chemistry
Z1 and Z2 are each independently O or CH2;
each R is independently H or halo; and
R4c is H, halo, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, or C1-C6 haloalkoxy.